Literature DB >> 6821935

Cytoplasmic creatine kinase isoenzymes quantitated in tissue specimens obtained at surgery.

P Urdal, K Urdal, J H Strømme.   

Abstract

Because previous reports have given inconsistent results, we re-examined the catalytic concentrations of cytoplasmic creatine kinase (CK) and of CK isoenzymes in 38 biopsies obtained from 19 different tissues. After homogenization and centrifugation many tissues showed high CK catalytic concentrations; 11 of them contained activity exceeding 50 U/g wet weight (Scandinavian recommended method). The highest specific activities were found in skeletal muscle (2400 U/g), brain (530 U/g), and myocardium (460 U/g). The separate isoenzyme activities were estimated by electrophoretic, anion-exchange chromatographic, immunoinhibiting, and radioimmunological methods. CK-BB was present in all tissues and, in fact, was the only cytoplasmic CK isoenzyme in 16 of the 19 tissues examined. CK-MM was the major isoenzyme of skeletal muscle and myocardium and was in addition observed in placenta, in trace amounts. CK-MB was present in high catalytic concentrations in myocardium (20% of total CK) and in low catalytic concentrations in skeletal muscle (1.1% of total CK).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6821935

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  13 in total

1.  Expression of creatine kinase isoenzyme genes during postnatal development of rat brain cerebellum: evidence for transcriptional regulation.

Authors:  Wei Shen; Dianna Willis; Yanping Zhang; Uwe Schlattner; Theo Wallimann; George R Molloy
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

2.  Selection of housekeeping genes for normalization of RT-PCR in hypoxic neural stem cells of rat in vitro.

Authors:  Lu Yao; Xinlin Chen; Yingfang Tian; Haixia Lu; Pengbo Zhang; Qindong Shi; Junfeng Zhang; Yong Liu
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

3.  The upstream muscle-specific enhancer of the rat muscle creatine kinase gene is composed of multiple elements.

Authors:  R A Horlick; P A Benfield
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

4.  Identification of a novel TA-rich DNA binding protein that recognizes a TATA sequence within the brain creatine kinase promoter.

Authors:  G M Hobson; M T Mitchell; G R Molloy; M L Pearson; P A Benfield
Journal:  Nucleic Acids Res       Date:  1988-09-26       Impact factor: 16.971

5.  Identification of cis-acting regulatory elements in the promoter region of the rat brain creatine kinase gene.

Authors:  G M Hobson; G R Molloy; P A Benfield
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

6.  Brain and muscle creatine kinase genes contain common TA-rich recognition protein-binding regulatory elements.

Authors:  R A Horlick; G M Hobson; J H Patterson; M T Mitchell; P A Benfield
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

7.  Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage.

Authors:  I M Skogseid; H K Nordby; P Urdal; E Paus; F Lilleaas
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

8.  Mouse p53 represses the rat brain creatine kinase gene but activates the rat muscle creatine kinase gene.

Authors:  J Zhao; F I Schmieg; D T Simmons; G R Molloy
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

9.  Circulating protein synthesis rates reveal skeletal muscle proteome dynamics.

Authors:  Mahalakshmi Shankaran; Chelsea L King; Thomas E Angel; William E Holmes; Kelvin W Li; Marc Colangelo; John C Price; Scott M Turner; Christopher Bell; Karyn L Hamilton; Benjamin F Miller; Marc K Hellerstein
Journal:  J Clin Invest       Date:  2015-12-14       Impact factor: 14.808

10.  Dissociated expression of mitochondrial and cytosolic creatine kinases in the human brain: a new perspective on the role of creatine in brain energy metabolism.

Authors:  Matthew T J Lowe; Eric H Kim; Richard L M Faull; David L Christie; Henry J Waldvogel
Journal:  J Cereb Blood Flow Metab       Date:  2013-05-29       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.